Mednax Inc Stock
Mednax Inc Stock
Heavy losses for Mednax Inc today as the stock fell by -€0.800 (-3.480%).
Our community identified positive and negative aspects for Mednax Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Mednax Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Mednax Inc in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | -3.480% | 1.770% | -1.709% | 86.992% | 25.000% | 74.242% | -17.857% |
| Molina Healthcare | 1.000% | 1.772% | -15.746% | 27.819% | 18.014% | -39.117% | -21.180% |
| Chemed Corp. | -1.260% | 1.282% | 11.268% | 28.108% | 30.220% | - | - |
| Davita Inc. | -0.470% | -21.640% | -21.947% | 43.056% | 65.025% | 58.753% | 40.468% |
Comments
Pediatrix Medical Group (MD) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat